Extended treatment with interferon and ribavirin in a hemodialysis patient with chronic hepatitis C

Bibliographic Details
Main Author: Vigani,Aline Gonzalez
Publication Date: 2010
Other Authors: Pavan,Maria HP, Tozzo,Raquel, Gonçales,Eduardo SL, Lazarini,Maria SK, Oliveira,Alexandre Macedo de, Gonçales Jr,Fernando L
Format: Report
Language: eng
Source: Brazilian Journal of Infectious Diseases
Download full: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702010000200016
Summary: Hemodialysis patient with chronic HCV infection,who was started on monotherapy with interferon.Qualitative HCV RNA remained positive at 12 weeks of treatment; ribavirin was associated. HCV RNA was negative at week 24 and treatment was extended to 72 weeks. HCV RNA negative six months after treatment.
id BSID-1_0064c12986afd2621705ef2ee7da240d
oai_identifier_str oai:scielo:S1413-86702010000200016
network_acronym_str BSID-1
network_name_str Brazilian Journal of Infectious Diseases
repository_id_str
spelling Extended treatment with interferon and ribavirin in a hemodialysis patient with chronic hepatitis Chepatitis C virushemodialysistreatmentinterferonribavirinHemodialysis patient with chronic HCV infection,who was started on monotherapy with interferon.Qualitative HCV RNA remained positive at 12 weeks of treatment; ribavirin was associated. HCV RNA was negative at week 24 and treatment was extended to 72 weeks. HCV RNA negative six months after treatment.Brazilian Society of Infectious Diseases2010-04-01info:eu-repo/semantics/reportinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702010000200016Brazilian Journal of Infectious Diseases v.14 n.2 2010reponame:Brazilian Journal of Infectious Diseasesinstname:Brazilian Society of Infectious Diseases (BSID)instacron:BSID10.1590/S1413-86702010000200016info:eu-repo/semantics/openAccessVigani,Aline GonzalezPavan,Maria HPTozzo,RaquelGonçales,Eduardo SLLazarini,Maria SKOliveira,Alexandre Macedo deGonçales Jr,Fernando Leng2010-06-11T00:00:00Zoai:scielo:S1413-86702010000200016Revistahttps://www.bjid.org.br/https://old.scielo.br/oai/scielo-oai.phpbjid@bjid.org.br||lgoldani@ufrgs.br1678-43911413-8670opendoar:2010-06-11T00:00Brazilian Journal of Infectious Diseases - Brazilian Society of Infectious Diseases (BSID)false
dc.title.none.fl_str_mv Extended treatment with interferon and ribavirin in a hemodialysis patient with chronic hepatitis C
title Extended treatment with interferon and ribavirin in a hemodialysis patient with chronic hepatitis C
spellingShingle Extended treatment with interferon and ribavirin in a hemodialysis patient with chronic hepatitis C
Vigani,Aline Gonzalez
hepatitis C virus
hemodialysis
treatment
interferon
ribavirin
title_short Extended treatment with interferon and ribavirin in a hemodialysis patient with chronic hepatitis C
title_full Extended treatment with interferon and ribavirin in a hemodialysis patient with chronic hepatitis C
title_fullStr Extended treatment with interferon and ribavirin in a hemodialysis patient with chronic hepatitis C
title_full_unstemmed Extended treatment with interferon and ribavirin in a hemodialysis patient with chronic hepatitis C
title_sort Extended treatment with interferon and ribavirin in a hemodialysis patient with chronic hepatitis C
author Vigani,Aline Gonzalez
author_facet Vigani,Aline Gonzalez
Pavan,Maria HP
Tozzo,Raquel
Gonçales,Eduardo SL
Lazarini,Maria SK
Oliveira,Alexandre Macedo de
Gonçales Jr,Fernando L
author_role author
author2 Pavan,Maria HP
Tozzo,Raquel
Gonçales,Eduardo SL
Lazarini,Maria SK
Oliveira,Alexandre Macedo de
Gonçales Jr,Fernando L
author2_role author
author
author
author
author
author
dc.contributor.author.fl_str_mv Vigani,Aline Gonzalez
Pavan,Maria HP
Tozzo,Raquel
Gonçales,Eduardo SL
Lazarini,Maria SK
Oliveira,Alexandre Macedo de
Gonçales Jr,Fernando L
dc.subject.por.fl_str_mv hepatitis C virus
hemodialysis
treatment
interferon
ribavirin
topic hepatitis C virus
hemodialysis
treatment
interferon
ribavirin
description Hemodialysis patient with chronic HCV infection,who was started on monotherapy with interferon.Qualitative HCV RNA remained positive at 12 weeks of treatment; ribavirin was associated. HCV RNA was negative at week 24 and treatment was extended to 72 weeks. HCV RNA negative six months after treatment.
publishDate 2010
dc.date.none.fl_str_mv 2010-04-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/report
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format report
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702010000200016
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702010000200016
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/S1413-86702010000200016
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Brazilian Society of Infectious Diseases
publisher.none.fl_str_mv Brazilian Society of Infectious Diseases
dc.source.none.fl_str_mv Brazilian Journal of Infectious Diseases v.14 n.2 2010
reponame:Brazilian Journal of Infectious Diseases
instname:Brazilian Society of Infectious Diseases (BSID)
instacron:BSID
instname_str Brazilian Society of Infectious Diseases (BSID)
instacron_str BSID
institution BSID
reponame_str Brazilian Journal of Infectious Diseases
collection Brazilian Journal of Infectious Diseases
repository.name.fl_str_mv Brazilian Journal of Infectious Diseases - Brazilian Society of Infectious Diseases (BSID)
repository.mail.fl_str_mv bjid@bjid.org.br||lgoldani@ufrgs.br
_version_ 1754209241157074944